96 related articles for article (PubMed ID: 2245174)
21. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
Loprinzi CL; Michalak JC; Schaid DJ; Mailliard JA; Athmann LM; Goldberg RM; Tschetter LK; Hatfield AK; Morton RF
J Clin Oncol; 1993 Apr; 11(4):762-7. PubMed ID: 8478668
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of increased lipolysis in cancer cachexia.
Agustsson T; Rydén M; Hoffstedt J; van Harmelen V; Dicker A; Laurencikiene J; Isaksson B; Permert J; Arner P
Cancer Res; 2007 Jun; 67(11):5531-7. PubMed ID: 17545636
[TBL] [Abstract][Full Text] [Related]
23. Potential applications of high-dose megestrol acetate in breast cancer.
Abrams JS; Gutheil J; Aisner J
Oncology; 1992; 49 Suppl 2():12-7. PubMed ID: 1461620
[TBL] [Abstract][Full Text] [Related]
24. Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy.
Cruz JM; Muss HB; Brockschmidt JK; Evans GW
Semin Oncol; 1990 Dec; 17(6 Suppl 9):63-7. PubMed ID: 2259928
[TBL] [Abstract][Full Text] [Related]
25. [Appetite increase and weight gain following treatment with megestrol acetate in patients with advanced cancer].
Marcos Sánchez F; Juárez Ucelay F; Aparicio Martínez JC; Durán Pérez-Navarro A
An Med Interna; 1994 Aug; 11(8):415-6. PubMed ID: 7772697
[No Abstract] [Full Text] [Related]
26. High-dose megestrol acetate in the treatment of postmenopausal women with advanced breast cancer.
Tchekmedyian NS; Tait N; Aisner J
Semin Oncol; 1986 Dec; 13(4 Suppl 4):20-5. PubMed ID: 3798125
[TBL] [Abstract][Full Text] [Related]
27. Overview of hormonal therapy in advanced breast cancer.
Schacter LP; Rozencweig M; Canetta R; Kelley S; Nicaise C; Smaldone L
Semin Oncol; 1990 Dec; 17(6 Suppl 9):38-46. PubMed ID: 2148026
[TBL] [Abstract][Full Text] [Related]
28. Lipolytic activity of progesterone and synthetic progestins on rat parametrial adipocytes in vitro.
Dorai V; Hazard MC; Paris J; Delansorne R
J Pharmacol Exp Ther; 1991 Aug; 258(2):620-5. PubMed ID: 1865361
[TBL] [Abstract][Full Text] [Related]
29. Appetite stimulation and weight gain with megestrol acetate.
Aisner J; Parnes H; Tait N; Hickman M; Forrest A; Greco FA; Tchekmedyian NS
Semin Oncol; 1990 Dec; 17(6 Suppl 9):2-7. PubMed ID: 2259925
[TBL] [Abstract][Full Text] [Related]
30. Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia.
Von Roenn JH
Oncology; 1994 Oct; 51 Suppl 1():19-24. PubMed ID: 7970504
[TBL] [Abstract][Full Text] [Related]
31. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
Buzdar A; Jonat W; Howell A; Jones SE; Blomqvist C; Vogel CL; Eiermann W; Wolter JM; Azab M; Webster A; Plourde PV
J Clin Oncol; 1996 Jul; 14(7):2000-11. PubMed ID: 8683230
[TBL] [Abstract][Full Text] [Related]
32. A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss.
McMillan DC; Wigmore SJ; Fearon KC; O'Gorman P; Wright CE; McArdle CS
Br J Cancer; 1999 Feb; 79(3-4):495-500. PubMed ID: 10027319
[TBL] [Abstract][Full Text] [Related]
33. Megestrol acetate vs cyproheptadine in the treatment of weight loss associated with HIV infection.
Summerbell CD; Youle M; McDonald V; Catalan J; Gazzard BG
Int J STD AIDS; 1992; 3(4):278-80. PubMed ID: 1504160
[TBL] [Abstract][Full Text] [Related]
34. Megestrol acetate for treatment of anorexia and cachexia associated with human immunodeficiency virus infection.
Von Roenn JH; Murphy RL; Wegener N
Semin Oncol; 1990 Dec; 17(6 Suppl 9):13-6. PubMed ID: 2259923
[TBL] [Abstract][Full Text] [Related]
35. Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response.
Ettinger DS; Allegra J; Bertino JR; Bonomi P; Browder H; Byrne P; Carpenter J; Catalano R; Creech R; Dana B
Semin Oncol; 1986 Dec; 13(4 Suppl 4):9-14. PubMed ID: 3026052
[TBL] [Abstract][Full Text] [Related]
36. Thyroid hormone modulation of epinephrine-induced lipolysis in rat adipocytes: a possible role of calcium.
Goswami A; Rosenberg IN
Endocrinology; 1978 Dec; 103(6):2223-33. PubMed ID: 218806
[TBL] [Abstract][Full Text] [Related]
37. Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
Loprinzi CL; Bernath AM; Schaid DJ; Malliard JA; Athmann LM; Michalak JC; Tschetter LK; Hatfield AK; Morton RF
Oncology; 1994 Oct; 51 Suppl 1():2-7. PubMed ID: 7970505
[TBL] [Abstract][Full Text] [Related]
38. High-dose megestrol acetate for the treatment of advanced breast cancer: dose and toxicities.
Aisner J; Tchekmedyian NS; Moody M; Tait N
Semin Hematol; 1987 Apr; 24(2 Suppl 1):48-55. PubMed ID: 3589708
[TBL] [Abstract][Full Text] [Related]
39. [Supportive treatment with megestrol acetate during radio(chemo)therapy in patients with tumors in the head-neck area. A randomized study].
Fietkau R; Riepl M; Kettner H; Hinke A; Sauer R
Strahlenther Onkol; 1996 Mar; 172(3):162-8. PubMed ID: 8721265
[TBL] [Abstract][Full Text] [Related]
40. Suppression of cortisol responses to exogenous adrenocorticotrophic hormone, and the occurrence of side effects attributable to glucocorticoid excess, in cats during therapy with megestrol acetate and prednisolone.
Middleton DJ; Watson AD; Howe CJ; Caterson ID
Can J Vet Res; 1987 Jan; 51(1):60-5. PubMed ID: 3032391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
